Epigenetic field for cancerization: its cause and clinical implications.
作者信息
Ushijima Toshikazu
机构信息
Division of Epigenomics, National Cancer Center Research Institute, Japan.
出版信息
BMC Proc. 2013 Apr 4;7 Suppl 2(Suppl 2):K22. doi: 10.1186/1753-6561-7-S2-K22. eCollection 2013.
Abstract
摘要
相似文献
1
Epigenetic field for cancerization: its cause and clinical implications.
BMC Proc. 2013 Apr 4;7 Suppl 2(Suppl 2):K22. doi: 10.1186/1753-6561-7-S2-K22. eCollection 2013.
2
Epigenetic field cancerization in gastrointestinal cancers.
Cancer Lett. 2016 Jun 1;375(2):360-366. doi: 10.1016/j.canlet.2016.03.009. Epub 2016 Mar 10.
3
Mammary field cancerization: molecular evidence and clinical importance.
Breast Cancer Res Treat. 2009 Nov;118(2):229-39. doi: 10.1007/s10549-009-0504-0. Epub 2009 Aug 15.
4
Field cancerization in the colon: a role for aberrant DNA methylation?
Gastroenterol Rep (Oxf). 2014 Feb;2(1):16-20. doi: 10.1093/gastro/got039. Epub 2014 Jan 13.
5
Prostate field cancerization and exosomes: Association between CD9, early growth response 1 and fatty acid synthase.
Int J Oncol. 2020 Apr;56(4):957-968. doi: 10.3892/ijo.2020.4980. Epub 2020 Feb 10.
6
Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Gastric Cancer. 2017 Jan;20(1):136-145. doi: 10.1007/s10120-016-0593-5. Epub 2016 Jan 20.
7
Could stroma contribute to field cancerization?
Med Hypotheses. 2010 Jul;75(1):26-31. doi: 10.1016/j.mehy.2010.01.019. Epub 2010 Feb 9.
8
Surgical approach to the management of field cancerization: Own experience.
Dermatol Ther. 2020 Jul;33(4):e13621. doi: 10.1111/dth.13621. Epub 2020 Jul 1.
9
Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Breast Cancer Res. 2015 Sep 14;17(1):125. doi: 10.1186/s13058-015-0637-5.
10
An overview of the risk factors associated with multiple oral premalignant lesions with a case report of extensive field cancerization in a female patient.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):178-83. doi: 10.5507/bp.2013.092. Epub 2014 Jan 3.
引用本文的文献
1
Tumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system.
iScience. 2022 Apr 8;25(5):104217. doi: 10.1016/j.isci.2022.104217. eCollection 2022 May 20.
2
associated aberrant methylation genes in blood leukocyte and gastric mucosa.
J Cancer. 2021 Oct 28;12(24):7326-7333. doi: 10.7150/jca.64613. eCollection 2021.
3
GIDB: a knowledge database for the automated curation and multidimensional analysis of molecular signatures in gastrointestinal cancer.
Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz051.
4
Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer.
NMR Biomed. 2019 Oct;32(10):e4038. doi: 10.1002/nbm.4038. Epub 2019 Jan 4.
5
Is Associated with Expression through Promoter Methylation in Gastric Carcinogenesis.
Gut Liver. 2018 Jan 15;12(1):58-66. doi: 10.5009/gnl17263.
6
Tumor size is an independent risk predictor for metachronous colorectal cancer.
Oncotarget. 2016 Apr 5;7(14):17896-904. doi: 10.18632/oncotarget.7555.
7
Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis.
J Gastroenterol. 2016 Oct;51(10):949-60. doi: 10.1007/s00535-016-1176-2. Epub 2016 Feb 12.
8
Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival.
Clin Epigenetics. 2015 Oct 15;7:110. doi: 10.1186/s13148-015-0145-6. eCollection 2015.
9
The Fine LINE: Methylation Drawing the Cancer Landscape.
Biomed Res Int. 2015;2015:131547. doi: 10.1155/2015/131547. Epub 2015 Sep 13.
本文引用的文献
1
Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells.
Carcinogenesis. 2012 Dec;33(12):2384-90. doi: 10.1093/carcin/bgs294. Epub 2012 Sep 13.
2
Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.
Gastroenterology. 2012 Sep;143(3):550-563. doi: 10.1053/j.gastro.2012.07.009. Epub 2012 Jul 13.
3
Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection.
Gastric Cancer. 2012 Oct;15(4):382-8. doi: 10.1007/s10120-011-0126-1. Epub 2012 Jan 12.
4
Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers.
Clin Cancer Res. 2012 Feb 15;18(4):923-9. doi: 10.1158/1078-0432.CCR-11-2011. Epub 2011 Dec 28.
5
Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction.
Oncogene. 2012 Jan 19;31(3):342-51. doi: 10.1038/onc.2011.241. Epub 2011 Jun 20.
6
Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation.
Carcinogenesis. 2011 Jan;32(1):35-41. doi: 10.1093/carcin/bgq219. Epub 2010 Oct 27.
7
Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells.
Cancer Res. 2010 Feb 15;70(4):1430-40. doi: 10.1158/0008-5472.CAN-09-2755. Epub 2010 Feb 2.
8
Epigenetic field for cancerization.
J Biochem Mol Biol. 2007 Mar 31;40(2):142-50. doi: 10.5483/bmbrep.2007.40.2.142.
9
Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers.
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2317-21. doi: 10.1158/1055-9965.EPI-06-0436.
10
High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk.
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):989-95. doi: 10.1158/1078-0432.CCR-05-2096.
Zotero 插件